Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H R Hubbell

Showing results (31-40 of 35) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 35 results.
Annals of the New York Academy of Sciences|June 23, 1993
Specific RNA drug therapy of hepatitis virusesW A Carter, R J Suhadolnik, W E Müller, et al.
Journal of Biological Response Modifiers|October 1, 1987
Augmented antitumor effect of combined human natural interferon-alpha and mismatched double-stranded RNA treatment against a human malignant melanoma xenograftH R Hubbell, E C Pequignot, J Todd, et al.
The Journal of General Virology|February 1, 1995
A 2',5'-oligoadenylate analogue inhibits murine hepatitis virus strain 3 (MHV-3) replication in vitro but does not reduce MHV-3-related mortality or induction of procoagulant activity in susceptible miceR J Fingerote, B M Cruz, R M Gorczynski, et al.
Anticancer Research|September 1, 1991
Heterogeneous nuclear RNA from hairy cell leukemia patients activates 2',5'-oligoadenylate synthetaseH R Hubbell, P C Sheetz, S S Iogal, et al.
Cancer Immunology, Immunotherapy : CII|January 1, 1992
Antitumor effects of interleukin-2 and mismatched double-stranded RNA, individually and in combination, against a human malignant melanoma xenograftH R Hubbell, H E Vargas, K L Tsujimoto, et al.
Pageof 4

Showing results (31-40 of 35) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 35 results.
Annals of the New York Academy of Sciences|June 23, 1993
Specific RNA drug therapy of hepatitis virusesW A Carter, R J Suhadolnik, W E Müller, et al.
Journal of Biological Response Modifiers|October 1, 1987
Augmented antitumor effect of combined human natural interferon-alpha and mismatched double-stranded RNA treatment against a human malignant melanoma xenograftH R Hubbell, E C Pequignot, J Todd, et al.
The Journal of General Virology|February 1, 1995
A 2',5'-oligoadenylate analogue inhibits murine hepatitis virus strain 3 (MHV-3) replication in vitro but does not reduce MHV-3-related mortality or induction of procoagulant activity in susceptible miceR J Fingerote, B M Cruz, R M Gorczynski, et al.
Anticancer Research|September 1, 1991
Heterogeneous nuclear RNA from hairy cell leukemia patients activates 2',5'-oligoadenylate synthetaseH R Hubbell, P C Sheetz, S S Iogal, et al.
Cancer Immunology, Immunotherapy : CII|January 1, 1992
Antitumor effects of interleukin-2 and mismatched double-stranded RNA, individually and in combination, against a human malignant melanoma xenograftH R Hubbell, H E Vargas, K L Tsujimoto, et al.
Pageof 4